Results 271 to 280 of about 50,848 (283)

CDK Inhibitors

2013
Livia Pérez-Hidalgo, Sergio Moreno
openaire   +1 more source

CDK Phosphorylation

2007
Akie Shimotohno, Masaaki Umeda
openaire   +1 more source

Discovery of a Potent CDKs/FLT3 PROTAC With Enhanced Differentiation and Proliferation Inhibition for AML

European Journal of Medicinal Chemistry
Xiao-Wu Dong, Wenhai Huang, Xinfei Mao
exaly  

The Role of CDKs in the Regulation of the Monocyte/Macrophage Immune Response

Current Medicinal Chemistry
Yu P Baikova, Marina V Kubekina
exaly  

Anticancer Potential of Novel Benzothiazolyl Piperidine-3-Carboxamide Derivatives as CDKs and VEGFR2 Multi-Target Kinase Inhibitors

Journal of Computer-Aided Molecular Design
Manal A Alossaimi, Alhumaidi B Alabbas, Safar M Alqahtani   +2 more
exaly  

PERHARIDINES AS CDK INHIBITORS

2009
MEIJER LAURENT, BETTAYEB KARIMA, GALONS HERVE, DEMANGE LUC, OUMATA NASSIMA   +4 more
openaire   +3 more sources

CDK Inhibitors

2002
Jun-ya Kato, Kiichiro Tomoda, Yukinobu Arata, Toshiaki Tanaka, Noriko Yoneda-Kato   +4 more
openaire   +1 more source

Nanodrug Modified With Engineered Cell Membrane Targets CDKs to Activate aPD-L1 Immunotherapy Against Liver Metastasis of Immune-Desert Colon Cancer

Journal of Controlled Release
Tufeng Chen, Dongbing Ding, Tianyun Lan
exaly  

Research Progress of PROTAC-Degraded CDKs in the Treatment of Breast Cancer

Breast Cancer: Targets and Therapy
Jun Zhang, Shengjun Zhang, Kexin Zhao
exaly  

CDK inhibitor salts

2010
ZAMPIERI MASSIMO, AIROLDI ANNALISA, FORNARETTO MARIA GIOIA, BRASCA MARIA GABRIELLA   +3 more
openaire   +3 more sources